Datu, Baby Boy D.
HRN: 28-88-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CEFTAZIDIME 1GM (VIAL)
04/23/2026
04/30/2026
IV
102mg
Q12H
Neonatal Pneumonia VS Neontal Sepsis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines